Patent Expiries 2025-2030
Expected generic entries by indication area in the next years on the pharmaceutical market Germany
Generic entry after expiration patent / SPC / data protection
For several ATC codes, only 1 entry was counted per active ingredient (combination), only the first expiry for several SPCs
Code | Contents |
---|---|
A | Alimentary tract and metabolism |
B | Blood and blood forming organs |
C | Cardiovascular system |
D | Dermatologicals |
G | Genito-urinary system and sex hormones |
H | Systemic hormonal preparations, excluding sex hormones and insulins |
J | Antiinfectives for systemic use |
L | Antineoplastic and immunomodulating agents |
M | Musculo-skeletal system |
N | Nervous system |
P | Antiparasitic products, insecticides and repellents |
R | Respiratory system |
S | Sensory organs |
V | Various |
(List from: "ATC: Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology)
Over the next 6 years, generics products for more than 200 active ingredients / drug combinations can be expected, including products like Eylea, Eliquis, Forxiga, Trulicity, IMBRUVICA, OPDIVO. Ocrevus, Entresto,…